| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_666890496697e3a8b9a7c5ccdd38d769 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C235-74
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A01N37-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61Q19-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C235-80 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C235-74
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C235-80 |
| filingDate |
2008-04-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_96c169df41b55b13e0af162f633ffadf
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6e88caeb3f13775e65111fc9c6bf2c62
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1665b41d0dc2b1d881326907a1ced312
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_fe60363d9794b15916564d6673efd3ec |
| publicationDate |
2009-10-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
KR-20090104955-A |
| titleOfInvention |
New compounds that promote the secretion of human-derived antimicrobial peptides, methods for their preparation, and external skin preparations containing the same as active ingredients |
| abstract |
The present invention relates to a novel compound having a secretion promoting effect of the human-derived antimicrobial peptide β-defensin, cardelicidin, a preparation method thereof, and an external preparation composition for promoting antimicrobial peptide secretion containing the same as an active ingredient. , The compounds of the present invention promote the secretion of antimicrobial peptides, have a repair effect on damaged skin barriers, and are effective in healing wounds. The skin external preparation using the compound of the present invention as an active ingredient expresses the secretion of antimicrobial peptides in the skin and tissue organs in the body, so it is safe and can exert an effective antimicrobial effect on the sites that were difficult with conventional antimicrobial agents administered externally or internally. . |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2010121213-A3
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-102043294-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-103221383-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8802105-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-103221383-B
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8399220-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-102366360-B1 |
| priorityDate |
2008-04-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |